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Purpose: To examine the phytochemical constituents and verify the ethnomedical claim of Newbouldia 
laevis (P.Beauv.) Seeman ex Bureau Bignoniaceae in treating septic wounds and eye problems.  
Methods: Applying standard methods, the phytochemical constituents of the stem bark were examined 
while the antibacterial potentials of the methanol extract of the stem bark and its organic solvent 
fractions were tested on clinical bacterial isolates from infected wounds and eyes using the agar - well 
diffusion method. Ciprofloxacin and gentamicin were used as standard controls. The time-kill kinetics of 
the methanol stem bark extract and ciprofloxacin were determined using isolates of Staphyloccocus 
aureus. 
Results: Phytochemical screening of the stem bark revealed the presence of flavonoids, tannins, 
saponins and alkaloids with no traces of cyanogenic glycosides. The 65 bacterial pathogens isolated 
included Proteus mirabilis (26.0 %) and Pseudomonas aeurginosa (17.4 %) from non-diabetic patients’ 
wounds; Staphylococcus aureus (32.0 %) and Escherichia coli (16.0%) from diabetic patients’ wounds; 
Staphylococcus aureus (35.3%) and Pseudomonas aeruginosa (35.3 %) from infected eyes. The 
chloroform fraction was observed to be more active on Gram- negative organisms while the aqueous 
fraction was more active on Gram-positive organisms. Time-kill kinetics of Staphylococcus aureus 
showed that the extract was bactericidal (99.9 % killing) at MIC and 2 x MIC after 24 and 3 hours, 
respectively.  
Conclusion: The study has established that the stem bark of Newbouldia laevis has antibacterial 
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INTRODUCTION 
 
Newbouldia laevis Seem (Bignoniaceae) is 
commonly known as smooth Newbouldia or 
boundary tree. It is called ‘Aduruku’ in Hausa; 
‘Ogirisi’ in Igbo; ‘Ikhimi’ in Edo and ‘Akoko’ in 
Yoruba languages
[1]
. It grows to a height of 
about 7 - 8 (up to 15) meters, more usually a 
shrub of 2-3 metres, many – stemmed 




Newbouldia laevis is widely used in African 
folk medicine for the treatment of malaria and 
fever, stomach-ache, coughs, sexually 
transmitted diseases, tooth ache, breast 
cancer, and constipation
[3-5]
. In South Eastern 
and part of the Midwestern Nigeria, the plant 
is used for the treatment of septic wounds 
and eye problems
[6]
. The antimicrobial 
potential of methanol extract of the leaf has 
been reported in literature while the anti-
inflammatory and antimalarial activities of the 
root extract have also been documented 
[7, 8]
. 
Scientific reports on the phytochemical 
constituents of the plant revealed the 
presence of alkaloids and phenylpropanoids 





Wound infection is detrimental to wound 
healing which is a complex process that can 
be delayed by many potential factors
[10]
. A 
variety of disorders commonly affect the eye 
and vary in severity from mild but annoying 





As it has been asserted that medicinal plants 
constitute a continuous source of new 
compounds with the potential to act against 
multi-resistant bacteria
[12]
, this work was 
aimed at investigating the antibacterial 
potential of the methanol extracts of the stem 
bark of Newbouldia laevis against isolates 






Collection and preparation of the plant 
material  
 
The stem bark of Newbouldia laevis was 
collected in June 2007, at Themboga, Benin 
City, Nigeria. The identity of the plant was 
authenticated by Dr. Olufemi Shasanya, a 
taxonomist at the Forest Research Institute of 
Nigeria (FRIN), Ibadan. A herbarium 
specimen no. FHI0031505-0 was deposited 
at the Institute’s herbarium for reference. The 
stem bark was cut into pieces and dried in 
the oven at 50-60 
o
C for 6 days after which 
they were reduced to powder form with a 
milling machine. 
 
Phytochemical tests   
 





Extraction of plant material   
 
About 1750 g of the powdered stem bark was 
extracted with methanol (5l) using maceration 
method for 72 hours.  After filtration, the 
extract was concentrated to dryness (semi 
solid) using rotary evaporator. The dried 
extract (25.9 g, 1.48%) was kept in the 
refrigerator maintained at 4
0
C until required. 
 
Solvent – solvent partitioning of the 
methanol extract  
 
About 8g of the methanol extract of the stem 
bark was dissolved in methanol – water (1:1) 
and partitioned with chloroform (300 ml x 3). 
The chloroform and aqueous phases 
obtained were separately concentrated to 
dryness and weighed. 
 
Sources of the microorganisms used 
 
Following receipt of permission from the 
authorities of the University of Benin 
Teaching Hospital, Benin City, Nigeria, 
wound swabs were obtained from infected 
wounds of diabetic and non-diabetic patients 
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while eye specimens were obtained from the 
eye discharges of patients with eye problems 
at the Ophthalmology Clinic of the same 
hospital. All the bacterial organisms isolated 
were identified using conventional 
biochemical techniques
[15]
. The bacterial 
isolates were maintained on nutrient agar 
slants at 4 
0
C and subcultured at intervals of 





Preparation of the bacterial inocula  
 
Broth cultures of desired organisms were 
prepared by suspending two colonies of each 
organism in nutrient broth and incubated 
aerobically at 37 
0
C for 12 hours. 
Suspensions were adjusted to a turbidity of 
about 10
8
 colony forming units (cfu)/ml using 
0.5 McFarland Standard for visual 
comparison. Hundred fold dilutions were 





Screening for antibacterial activity  
 
By adopting a modified agar-well diffusion 
method 
[16]
, the screening of the methanol 
extract, its organic solvent fractions, and the 
standard antibacterial agents were carried 
out. 25ml of sterile molten nutrient agar 
cooled to about 40
0
C was aseptically seeded 
with 100 µl of the desired organism at a 
turbidity of approximately 10
6
 cfu/ml. The 
seeded agar was aseptically poured into 
sterile Petri dishes of 8.5cm (85mm) in 
diameter and allowed to set at room 
temperature. 
 
With the aid of a sterile cork borer, four 
uniform wells of 7mm in diameter were 
punched on each plate.  The wells were each 
filled with 0.1 ml of stock concentration to 
give a final srength of 10 mg/ml or 20 mg/ml 
of the extract; or 0.1 ml of ciprofloxacin or 
gentamicin solution to give a final 
concentration of 10 µg/ml which were used 
as positive control. A pre-diffusion time of 1 h 
was allowed before the plates were incubated 
aerobically at 37 
0
C for 18 - 24 h. The 
diameter of the zones of inhibition was 
measured to the nearest millimeter with a 
transparent millimeter rule. The effects of the 
chloroform and aqueous fractions were 
tested at 20 mg/ml concentration. The tests 
were carried out in replicates.  
 
Determination of minimal inhibitory 
concentration (MIC) and minimal bactericidal 
concentration (MBC) 
 
The modified method of [17] was employed 
to determine the MIC of the extract (MSE) 
and its aqueous fraction. Serial two-fold 
dilutions of 2ml each were made in a 
concentration range of 50 to 0.391 mg/ml of 
the extract and 25 to 1.5625 mg/ml of the 
aqueous fraction using double strength 
nutrient broth supplemented with 10 % 
glucose. The tubes were inoculated with 100 
µl of the desired organisms (at a turbidity of 
approximately 10
6 
cfu /ml) and incubated 
aerobically at 37 
0
C for 18 - 24 h. Microbial 
growth was determined by adding 20 µl of 
phenol red (0.2 %) indicator and observing a 
change in colour from red to yellow when 
there is microbial growth.  The lowest 
concentration that showed no change in 
colour was considered the MIC. The 
procedure was repeated using ciprofloxacin 
(16 - 0.031 µg/ml) and gentamicin (32 - 0.063 
µg/ml) and observing the tubes for turbidity. 
 
For MBC determination, 20 µl of the liquid 
from each tube that showed no change in 
colour for the extract (MSE) and the aqueous 
fraction (aMSE), and turbidity for reference 
antibacterial agents was plated on 
antibacterial agent-free nutrient agar. The 
plates were incubated aerobically at 37 
0
C for 
18 - 24 h and the lowest concentration that 




The effect of ½MIC, MIC and 2MIC 
concentrations of the methanol extract on the 
viability of two isolates of Staphylococcus 
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aureus was examined by the Time-killing 
method. The isolates used were those 
obtained from non-diabetic and eye isolates. 
 
The different concentrations of the MSE were 
prepared from a stock solution of 50 mg/ml 
using double strength nutrient broth. 
Overnight broth culture of the desired 
organism (200 µl) was placed in contact with 
a specified extract concentration. Viable 
counts were  determined at the beginning of 
incubation and at intervals (i.e. after 1, 2, 3, 
4, 5, 6 and 24 h) by withdrawing 100 µl 
aliquots of the extract-organism mixture, in 
order to determine the time it took the extract 
to eradicate all viable cells of the organisms. 
The same procedures were repeated using 




The diameter of zones of inhibition for 
antibacterial assays were expressed as mean 
+ S.E.M. Simple percentage was used to 






Phytochemical screening of the powdered 
sample of the stem bark of N. laevis revealed 
the presence of saponins, tannins, 
flavonoids, steroidal glycosides and alkaloids 
while cyanogenic glycosides and anthracene 




The clinical specimens revealed the presence 
of various bacterial species occurring in 
varying degrees in the wounds and infected 
eyes. In the non-diabetic patients, the 
bacterial organisms had Proteus mirabilis as 
the most predominant organism (6 out of 23 
patients; 26.1 %), whereas the isolates from 
the diabetic patient wounds predominantly 
produced Staphylococcus aureus (8 cases 
out of 25 representing 32 %). The isolates 
from the infected eyes yielded Staphy. 
aureus and  Pseudomonas aeruginosa, each 
constituting 35 % of the 17 isolates. While 
Citrobacter and Providencia species were 
found only in the wounds of non diabetic 
patients, the only occurrence of Klebsiella sp. 
was recorded in an infected eye.  The 
presence of Staph. aureus, Ps. aeruginosa 
and P. mirabilis  was common in all the 
specimen sources (Table 1). 
 
Table 1: Distribution of organisms obtained from 





















1 4.4 - - 2 11.8 
Enterococcus 
faecalis 
1 4.4 1 4 - - 
Enterobacter 
sp  
1 4.4 3 12 - - 
Escherichia 
coli 
2 8.7 4 16   
Providencia 
sp 
2 8.7 - - - - 
Proteus 
mirabilis 
6 26.1 3 12 2 11.8 
Proteus 
vulgaris 
2 8.7 1 4 - - 
Alcaligenes 
sp 
  2 8 - - 
Staph. aureus  3 13.0 8 32 6 35.3 

















Note: N = number of occurrences; F = frequency; CON = 
coagulase negative; Staph = Staphylococcus; Ps = 
Pseudomonas; sp = species 
 
Antibacterial activity of extract 
 
The methanol extract of the stem bark 
showed activity against the tested isolates 
except Escherichia coli and Providencia 
species which were obtained from the 
wounds of non diabetic patients but however 
exhibited activity against the E.coli obtained 
from the wound of diabetic patient. The 
extract was more active against Gram-
positive than Gram-negative organisms with 
Staphylococcus aureus being the most 
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susceptible. The Enterobacteria species, 
Enterococcus feacalis, Proteus vulgaris and 
Klebsiella species that showed resistance to 
the ciprofloxacin and gentamicin were 
observed to be susceptible to 10 and 20 mg 
of the extract. Staphylococcus. aureus 
obtained from the wounds of non diabetic 
patient and infected eyes were more 
susceptible to the extract than the one 
obtained from the wound of diabetic patient 
(Table 2). 
 
The activity of the extract was concentration 
dependent, with the effect at 20mg being 
slightly higher than the activity at 10mg 
although not in all the organisms. The organic 
solvent fractions were observed to exhibit 
different activities on the selected 
icroorganisms. While the antibacterial 
activities were observed to increase on some 
bacteria, the effects were concentrated in 
either the chloroform or the aqueous fraction 
(see Table 3). 
 
The organisms showed varying degrees of 
susceptibility to the extract at MIC and MBC. 
For some of the isolates, the same 
concentration of the extract that produced the 
MIC also was the MBC, while for others, the 
bactericidal concentrations was obtained at 
double MIC (Table 4). 
 
For the time-killing effects of the extract on 
the isolates of Staph. aureus obtained from 
the non diabetic patient and infected eye 
isolates, the extract produced significant 
reduction in the viable cell counts of the 
organisms. The MIC of the isolate obtained 
from the wound of non diabetic patient was 
6.5 mg/ml. At 2MIC, the extract completely 
eliminated all the viable cells of the organism 
in less than 6h (Fig 1).    
 
 
Table 2: Inhibitory effect of N. laevis stem bark methanol extract and standard antibacterial 
agents on groeth of bacterial isolates (mean ± SD) 
 
Zone of inhibition (mm)  
Bacterial isolate                            
 
Source Extract 





Citrobacter sp NS 10.0±0.4 11.6±0.4 15.4±0.5 10.6±0.4 
Enterobacter sp NS 10.0±0.0 10.0±0.0 - - 
Escherichia coli NS - - 11.4±0.2 - 
Staphylococcus aureus NS 16.6±0.2 18.8±0.2 26.6±0.2 23.6±0.4 
Enterococcus faecalis NS 11.4±0.5 15.0±0.3 Nottested - 
Proteus mirabilis NS 10.6±0.2 11.4±0.4 29.6±0.4 19.8±0.2 
Proteus vulgaris NS 11.6±0.2 13.0±0.0 23.6±0.4 29.4±0.4 
Providencia sp NS - - 39.8±0.2 24.6±0.2 
Alcaligenes sp DS 12.2±0.2 13.6±0.2 35.2±0.2 17.6±0.2 
Enterobacter sp DS 10.0±0.0 10.0±0.0 - - 
Enterococcus faecalis DS 11.0±0.3 12.0±0.4 Nottested - 
Escherichia coli DS 11.2±0.2 12.6±0.2 21.6±0.2 11.8±0.2 
Proteus vulgaris DS 11.4±0.2 12.4±0.2 - - 
Pseudomonas aeruginosa DS 11.6±0.2 12.6±0.2 27.0±0.4 15.4±0.2 
Staphylococcus aureus DS 11.0±0.0 11.6±0.2 21.4±0.2 16.4±0.4 
CON Staphylococcus ES 16.2±0.2 17.6±0.2 24.0±0.8 25.8±0.7 
Klebsiella sp ES 11.6±0.2 11.8±0.2 - - 
Proteus mirabilis  ES 10.0±0.0 12.4±0.2 35.6±0.4 30.0±0.0 
Pseudomonas aeruginosa ES 11.8±0.2 13.0±0.0 36.6±0.2 15.6±0.2 
Staphylococcus aureus ES 16.2±0.5 18.4±0.6 20.5±0.3 19.8±0.2 
Note: ES = infected eye; DS = wound of diabetic patient; NS = wound of non-diabetic patient; CON = coagulase 
negative; Cipro = ciprofloxacin; Gentam = gentamycin; - = no activity 
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Table 3: Zone of inhibition (mm) of bacterial 
isolates in agar treated with chloroform and 
aqueous fractions from the methanol extract of N. 
laevis stem bark (mean ± SD)  
 






Escherichia coli NS 10.7 ±0.3 0 
Enterobacter sp NS 0 0 
Staphylococcus 
aureus 
NS 19.7 ±0.3 19.7 ±0.3  
Staphylococcus 
aureus 
DS 11.0 ±0.0 14.0 ±3.0 
Enterococcus 
faecalis 
DS 13.0 ±3.0   0 
Enterobacter sp DS 12.3 ±0.3 0 
Escherichia coli DS 0 0 
Staphylococcus 
aureus 
ES 0 21.7 ±0.3 
Pseudomonas 
aeruginosa 
ES 15.3 ±0.3 13.0±0.0 
Proteus mirabilis ES 15.3 ±0.3 14.7 ±0.3 
 
ES = infected eye; DS = wound of diabetic patient; NS = 
wound of non-diabetic patient 
 
The MIC of 12.5 mg/ml could not produce 
complete elimination of the organism 
obtained from infected eye although a 
remarkable reduction in the viable cell count 
was obtained with 2MIC after the incubation 
period of 24 h. Both the MIC and 2MIC 
indicated an initial kill or reduction in the 
viable cell counts followed by bacteriostatic 
effect (Fig. 2).  
 
In all the concentrations of the Ciprofloxacin 
tested, the viable cell count of the two 
organisms significantly decreased below the 
control up to 6h after which there was 
resistance to the drug indicated by the 





Although the phytochemical and antimicrobial 
properties of N. laevis have been reported 
(7), a comparative study of the stem bark 
methanol extract on organisms isolated from 
wounds and infected eyes has not been 
considered. The predominance of the various 
organisms was observed to vary depending 
not only on the part of the body from which 
they were obtained but also on the 
physiological state of the subjects. While 
Staph. aureus and P. aeruginosa were 
observed to be predominant in the eye 
isolates, the organisms obtained from the 
wounds of diabetic and non-diabetic patients 
were dominated by Proteus and Staph. 
aureus, respectively.  The extract and the 
organic solvent fractions were considered 






Fig 1: Time-killing effect of different concentrations of 
methanol extract of the stem bark of Newbouldia 
laevis on the viable count of Staphylococcus aureus 
(non-dibetic wound isolate, NS). Key: ♦ = control; ■ = 





Fig 2: Time-killing effect of different concentrations of 
methanol extract of the stem bark of Newbouldia laevis 
on the viable count of Staphylococcus aureus (ES = eye 
isolate) Key: ♦ = control; ■ = ½MIC; ▲ = MIC; ● = 2MIC 
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Table 4: Minimum Inhibitory Concentration (MIC) and Minimum Bactericidal Concentration (MBC) of 
methanol extract of the stem bark (mg/ml) of Newbouldia laevis and of reference antibacterial agents  
 
Bacterial isolate Source Ciprofloxacin (µg/ml) Gentamicin (µg/ml) Extract (mg/ml) 
  MIC MBC MIC ic MIC MBC MIC ic MIC MBC 
Citrobacter sp  NS 16 16 R 32 32 R 12.5 25 
Enterobacter sp NS >16 >16 R 32 >32 R 12.5 12.5 
Escherichia coli NS >16 >16 R >32 >32 R 25 50 
Proteus mirabilis NS <0.03 0.5 S 4 4 S 12.5 25 
Proteus vulgaris NS 16 >16 R 8 16 R 3.125 6.25 
Providencia sp NS <16 ≥16 R <2 ≥2 S 12.5 25 
Staphylococcus aureus  NS 1 >1 S 4 4 R 6.25 12.5 
Enterococcus faecalis NS NT NT NT 32 32 R 3.125 6.25 
Alcaligenes sp DS <0.5 ≥0.5 S >4 >4 R 6.25 12.5 
Enterobacter sp DS >16 >16 R >32 >32 R 12.5 25 
Escherichia coli DS >1 >1 R >32 >32 R 6.25 12.5 
Proteus vulgaris DS >16 >16 R >32 >32 R 6.25 12.5 
Pseudomonas aeruginosa DS <0.5 ≥0.5 S >4 >4 R 3.125 12.5 
Staphylococcus aureus DS <0.5 ≥0.5 S <1 ≥1 S 6.25 12.5 
Enterococcus faecalis DS NT NT NT >256 >256 R 12.5 25 
CON Staph. ES 0.5 1 S 1 2 S 3.125 6.25 
Klebsiella sp ES >16 >16 R >32 >32 R 12.5 12.5 
Proteus mirabilis ES 1 >1 S >32 >32 R 6.25 6.25 
Pseudomonas aeruginosa ES >4 >4 R >32 >32 R 12.5 25 
Staph. aureus ES 0.5 1 S 8 8 R 12.5 12.5 
  
R = resistant; S = susceptible;  NT = not determined; ES = infected eye; DS = wound of diabetic patient; NS = wound of 
non-diabetic patient 
 
The extract showed remarkable activities 
against both the Gram-negative and Gram-
positive bacteria. The Gram-negative 
bacterial organisms are generally regarded 
more difficult to inhibit due to the presence of 
a thick murein layer that tends to prevent the 
entry of inhibitors
[20,21]
. However, the extract 
of N. laevis inhibited some Gram-negative 
bacteria such as Enterobacter and Klebsiella 
species both at 10 and 20 mg. It is 
remarkable to note that Staphylococci which 
have a record of developing resistance 
rapidly and successfully to antibiotics 
[22]
 were 
the most susceptible to the methanol stem 
bark extract. The E. coli and Providencia 
(obtained from the wounds of non diabetic 
patients) specie which earlier exhibited 
resistance to the extract at 20 mg were 
observed to have MIC and MBC of 25 and 50 
mg/ml. These indicated that the 
concentrations used earlier were grossly 
ineffective in subduing the growth of the 
organisms. Also, based on these higher MIC 
and MBC than others, the two organisms 
being Gram negatives can be said to be the 
most resistant to the extract. 
 
The times required to reduce or eliminate 
Staph. aureus isolates from non-diabetic and 
infected eyes showed some variation 
probably due to variations in the sources of 
the organisms. From the results, the isolate 
obtained from the wounds of non-diabetic 
subjects was eliminated completely in less 
than 6 h at twice the MIC and 24 h at the 
MIC; although there was no total elimination 
of the isolate  obtained from the eye, the 
extract showed pronounced reduction in the 
population of the organism at two times the 
MIC. The susceptibility exhibited by the 
microorganisms to the extract as well as the 
aqueous and chloroform fractions may be 
attributed to the presence of different groups 
of constituents that may be acting 
synergistically with one another. Partitioning 
plant extracts in two immiscible solvents 
enables the separation of the plant active 
constituents with the eventual aim of locating 
where the active constituents could be 
residing. In this work, the results obtained 
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show that the constituents of the extract were 
responsible for the observed antibacterial 
activities and it is important to note that, for 
some of the organisms, the inhibitory effects 
became more pronounced for the organic 
solvent fraction. The overall observed 
antibacterial activities of the extracts could be 
traced to the presence of the secondary 
metabolites like tannins, alkaloids, flavonoids 
reported present in the plant material. The 
results of this work have justified the 
ethnomedicinal claim of the stem bark of N. 





The results obtained in this work indicate that 
the stem bark of N. laevis possesses natural 
potential to inhibit the growth of various 
organisms. The observed antibacterial effects 
may due to the presence of secondary 
metabolites in the plant.  Our findings justify 
the ethnomedicinal claim of the stem bark of 
N. laevis in treating septic wounds and 
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